.RESEARCH EMPHASIZE.06 August 2024.
A sizable randomized controlled trial with cisgender females highlights the difficulties of fidelity to a day-to-day dental preexposure prevention routine and also displays that twice-yearly treatment of lenacapavir can easily keep successful HIV protection degrees over 6 months.